Finally, despite TGFB2 and TGFBR3 being preferentially expressed in the OC3 tumor group (Figure S4b), in clinical samples, both genes were not significantly enriched in the tumor cell type (Figure 4b). This evidence concerns the gene TGFB2 and neoplasm.